Poster Poster Program Clinical Trials Specialty Program

Rectal Spacer Quality and Rectal Dose Sparing In Prostate Sabr: Evidence from a Prospective Clinical Trial

Poster
AAPM2026 Abstract 26298 POTENC SQS.pdf Hosted by AAPM · 0.6 MB
Abstract
Purpose

Rectal spacers are widely used in prostate stereotactic ablative radiotherapy (SAbR) to reduce rectal dose; however, their value as a practical, planning-oriented QA tool remains underdefined. Using real-world clinical trial data, this study evaluates whether a clinically assigned spacer quality score (SQS), based on prostate–rectum separation on planning imaging, predicts achievable rectal dosimetric sparing in routine prostate SAbR planning.

Methods

A total of 110 prostate SAbR cases from a multi-institutional prospective clinical trial (POTEN-C) were retrospectively analyzed. Spacer quality was assessed using a clinically assigned spacer quality score (SQS), derived from geometric separation between the prostate/PTV and rectum on planning imaging. Rectal dosimetric endpoints—including rectal hotspot dose (D0.03cc) and high-dose volume metrics—were extracted and correlated with spacer quality to evaluate the planning and QA relevance of SQS. Analyses focused on identifying dosimetric trends attributable to spacer quality rather than spacer presence alone.

Results

Higher SQS were associated with improved rectal dosimetry, with higher SQS achieving lower rectal hotspot dose (D0.03cc) and reduced high-dose rectal exposure. Associations between SQS and early gastrointestinal (GI) quality-of-life (QoL) outcomes were weak overall; however, a clear threshold effect was observed. Patients with very low spacer quality (SQS = 0, e.g 0. Together, these findings indicate that SQS serves both as a planning-oriented quality assurance metric and as a threshold-based indicator of early GI QoL risk.

Conclusion

In a real-world prostate SAbR cohort, a clinically used spacer quality score provides a simple, planning-oriented QA metric that anticipates rectal dosimetric benefit. Beyond confirming spacer presence, spacer quality assessment informs planning decision-making by flagging cases in which achievable rectal sparing is constrained, supporting appropriate planning expectations in routine prostate SAbR practice.

People

Related

Similar sessions

Poster GPD-T-1080 Poster Program Exhibit Hall | Poster Lounge
Jul 19 · 15:15
A Medical Physics–Driven Clinical Trial of Temporally Modulated Pulsed Radiotherapy (NRG-CC017)

To design and validate reliable treatment planning and delivery verification methods for TMPRT in the phase III NRG CC-017 trial, which compares TMPRT to standard radiotherapy in adults with newly diagnosed MGMT-unmethylated glio...

Christian Velten, PhD
Clinical Trials Specialty Program 0 people interested
Poster GPD-T-40 Poster Program Exhibit Hall | Poster Lounge
Jul 19 · 15:15
Deep Learning-Based LS-SCLC Patient Selection for the New First-Line Treatment Using High-Dose Hyperfractionated SIB Radiotherapy

To develop risk-stratification and prognosis-prediction models for limited-stage small cell lung cancer (LS-SCLC) patients, suggesting potential candidates that may benefit from the new treatment protocol using high-dose hyperfra...

Yibao Zhang
Clinical Trials Specialty Program 0 people interested